Filtros de búsqueda

Lista de obras de Robert Landewé

14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis

artículo científico publicado en 2015

14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage

artículo científico publicado en 2014

2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis

scientific article published on June 2011

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

artículo científico publicado en 2017

2016 update of the EULAR recommendations for the management of early arthritis

artículo científico publicado en 2016

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

artículo científico publicado en 2019

A psychometric analysis of outcome measures in peripheral spondyloarthritis

artículo científico publicado en 2015

A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial

artículo científico publicado en 2010

A single determination of C-reactive protein does not suffice to declare a patient with a diagnosis of axial spondyloarthritis 'CRP-negative'

article published in 2018

A stratified model for health outcomes in ankylosing spondylitis

artículo científico publicado en 2011

ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort

artículo científico publicado en 2012

Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis

artículo científico publicado en 2016

Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort

scientific article published on 15 September 2019

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

artículo científico publicado en 2011

Analysis of integrated radiographic data from two long-term, open-label extension studies of adalimumab for the treatment of rheumatoid arthritis

artículo científico publicado en 2015

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states

artículo científico publicado en 2018

Ankylosing Spondylitis and Axial Spondyloarthritis

artículo científico publicado en 2016

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2013

Are conventional radiographs still of value?

artículo científico publicado en 2016

Are syndesmophytes most prevalent in the lumbar or in the cervical spine in patients with ankylosing spondylitis and do they develop in a specific direction?

artículo científico publicado en 2012

Aspects of validity of the self-administered comorbidity questionnaire in patients with ankylosing spondylitis

artículo científico publicado en 2014

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years

scientific article published on 24 August 2009

Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study

artículo científico publicado en 2002

Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients

artículo científico publicado en 2006

Association of the different types of radiographic damage with physical function in patients with rheumatoid arthritis: analysis of the RAPID trials

artículo científico publicado en 2016

Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study

artículo científico publicado en 2007

Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference

artículo científico publicado en 2021

Bone marrow edema on magnetic resonance imaging (MRI) of the sacroiliac joints is associated with development of fatty lesions on MRI over a 1-year interval in patients with early inflammatory low back pain: a 2-year followup study

artículo científico publicado en 2014

COVID-19 and how evidence of a new disease evolves

artículo científico publicado en 2020

COVID-19-induced hyperinflammation, immunosuppression, recovery and survival: how causal inference may help draw robust conclusions

artículo científico publicado en 2021

Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high-sensitivity c-reactive protein is used: an analysis in the DESIR cohort

artículo científico publicado en 2015

Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis

scientific article published on 01 January 2010

Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis

artículo científico publicado en 2007

Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example

artículo científico publicado en 2014

Cardiovascular and selected comorbidities in early arthritis and early spondyloarthritis, a comparative study: results from the ESPOIR and DESIR cohorts

artículo científico publicado en 2015

Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients

artículo científico publicado en 2015

Challenges in demonstrating the effectiveness of multidisciplinary treatment on quality of life, participation and health care utilisation in patients with fibromyalgia: a randomised controlled trial

artículo científico publicado el 10 de octubre de 2012

Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS.

artículo científico publicado en 2014

Clinical Tools to Assess and Monitor Spondyloarthritis

artículo científico publicado en 2015

Clinical and Imaging Signs of Spondyloarthritis in First-Degree Relatives of HLA-B27-Positive Ankylosing Spondylitis Patients: The Pre-Spondyloarthritis (Pre-SpA) Cohort Study

artículo científico publicado en 2016

Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety

artículo científico publicado en 2016

Comparative construct validity of three presenteeism instruments in workers with musculoskeletal complaints: a prospective cohort study

scientific article published on 01 August 2020

Composite measures in psoriatic arthritis: GRAPPA 2008.

artículo científico publicado en 2010

Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis

artículo científico publicado en 2012

Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

artículo científico publicado en 2010

DAS steered therapy in clinical practice; cross-sectional results from the METEOR database

artículo científico publicado en 2016

Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group

artículo científico publicado en 2016

Defining an optimal referral strategy for patients with a suspicion of axial spondyloarthritis: what is really important? Response to: 'Evaluating the ASAS recommendations for early referral of axial spondyloarthritis in patients with chronic low ba

artículo científico publicado en 2015

Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group

artículo científico publicado en 2012

Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.

artículo científico

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology

artículo científico publicado en 2014

Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis

artículo científico

Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials

artículo científico publicado en 2007

Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study

artículo científico publicado en 2011

Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis

artículo científico publicado en 2017

Digital ulcers predict a worse disease course in patients with systemic sclerosis

artículo científico publicado en 2015

Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes

article

Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?

artículo científico publicado en 2015

Disease Activity, Physical Function, and Radiographic Progression After Longterm Therapy with Adalimumab Plus Methotrexate: 5-Year Results of PREMIER

artículo científico publicado el 1 de octubre de 2010

Disease activity decrease is associated with improvement in work productivity over 1 year in early axial spondyloarthritis (SPondyloArthritis Caught Early cohort).

artículo científico publicado en 2017

Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort

artículo científico publicado en 2015

Do ethnicity, degree of family relationship, and the spondyloarthritis subtype in affected relatives influence the association between a positive family history for spondyloarthritis and HLA-B27 carriership? Results from the worldwide ASAS cohort

Do extra-articular manifestations influence outcome in ankylosing spondylitis? 12-year results from OASIS.

artículo científico publicado en 2016

Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?: Data from the SPACE cohort

artículo científico publicado en 2016

EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria

artículo científico publicado en 2013

EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

artículo científico publicado en 2010

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

artículo científico publicado en 2020

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

artículo científico publicado en 2010

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

artículo científico publicado en 2014

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

artículo científico publicado en 2017

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

artículo científico publicado en 2020

EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis

artículo científico

Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

scientific article published on 06 May 2010

Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis

artículo científico publicado en 2017

Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

artículo científico publicado en 2017

Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study

artículo científico publicado en 2018

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

scientific article published in The Lancet

Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

artículo científico publicado en 2017

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis

artículo científico

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

artículo científico publicado en 2017

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

artículo científico publicado en 2014

Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

artículo científico publicado en 2017

Evaluating quality of care in rheumatoid arthritis: the patient perspective

artículo científico publicado en 2017

Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study

artículo científico publicado en 2013

Existing joint erosions increase the risk of joint space narrowing independently of clinical synovitis in patients with early rheumatoid arthritis

artículo científico publicado en 2015

Expert agreement confirms that negative changes in hand and foot radiographs are a surrogate for repair in patients with rheumatoid arthritis

artículo científico publicado en 2007

Five-year follow-up of radiographic sacroiliitis: progression as well as improvement?

artículo científico publicado en 2016

Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitis

artículo científico publicado en 2016

From inhibition of radiographic progression to maintaining structural integrity: a methodological framework for radiographic progression in rheumatoid arthritis and psoriatic arthritis clinical trials

artículo científico publicado el 25 de abril de 2013

Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study

artículo científico publicado en 2015

Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study

artículo científico publicado en 2015

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

artículo científico publicado en 2009

Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort

artículo científico publicado en 2014

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

artículo científico publicado en 2020

How Do Gastrointestinal or Liver Comorbidities Influence the Choice of Pain Treatment in Inflammatory Arthritis? A Cochrane Systematic Review

artículo científico publicado el 1 de septiembre de 2012

How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?

artículo científico publicado en 2007

How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?

artículo científico publicado en 2005

How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.

artículo científico

Imaging in ankylosing spondylitis

artículo científico publicado en 2006

Imaging in spondylitis

artículo científico publicado en 2005

Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost

artículo científico publicado en 2010

Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies

Impact of replacing radiographic sacroiliitis by magnetic resonance imaging structural lesions on the classification of patients with axial spondyloarthritis

artículo científico publicado en 2018

In Early Axial Spondyloarthritis, Increasing Disease Activity Is Associated with Worsening of Health-related Quality of Life over Time

artículo científico publicado en 2018

In patients with axial spondyloarthritis, inflammation on MRI of the spine is longitudinally related to disease activity only in men: 2 years of the axial spondyloarthritis DESIR cohort

artículo científico publicado en 2017

Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patien

artículo científico publicado en 2019

Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial

Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity

scholarly article

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study

artículo científico publicado en 2013

International spondyloarthritis interobserver reliability exercise - the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis

article

International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures

artículo científico publicado en 2007

Intra-articular etanercept treatment in inflammatory arthritis: A randomized double-blind placebo-controlled proof of mechanism clinical trial validating TNF as a potential therapeutic target for local treatment

artículo científico publicado en 2015

Is radiographic progression in radiographic axial spondyloarthritis related to matrix metalloproteinase degradation of extracellular matrix?

artículo científico publicado en 2018

Is the Site of Back Pain Related to the Location of Magnetic Resonance Imaging Lesions in Patients With Chronic Back Pain? Results From the Spondyloarthritis Caught Early Cohort

artículo científico publicado en 2016

Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts

artículo científico publicado en 2017

Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis?

artículo científico publicado en 2007

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase

scientific article published in The Lancet

Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARD.

artículo científico publicado en 2016

Lessons to be learned from serum biomarkers in psoriasis and IBD - the potential role in SpA.

artículo científico publicado en 2016

Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial

artículo científico publicado en 2008

Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis

artículo científico publicado en 2015

Linear extrapolation of missing radiographic change scores in clinical trials does not spuriously overestimate group radiographic changes in rheumatoid arthritis

artículo científico publicado en 2016

Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension

artículo científico publicado en 2013

Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year efficacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label exten

artículo científico publicado en 2013

MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis

artículo científico publicado en 2015

Magnetic Resonance Imaging of the Sacroiliac Joints Indicating Sacroiliitis According to the Assessment of SpondyloArthritis international Society Definition in Healthy Individuals, Runners, and Women With Postpartum Back Pain.

artículo científico publicado en 2018

Magnetic resonance imaging changes of sacroiliac joints in patients with recent-onset inflammatory back pain: inter-reader reliability and prevalence of abnormalities

artículo científico publicado en 2006

Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis

artículo científico publicado en 2004

Metric Properties of the SPARCC Score of the Sacroiliac Joints - Data from Baseline, 3-month, and 12-month Followup in the SPACE Cohort

artículo científico publicado en 2015

Minimal disease activity for rheumatoid arthritis: a preliminary definition

artículo científico publicado en 2005

Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment.

artículo científico publicado en 2018

Multiple computer-based methods of measuring joint space width can discriminate between treatment arms in the COBRA trial -- Update of an ongoing OMERACT project

artículo científico publicado en 2009

Neutral lateral fingertip-to-floor distance can be derived from height

artículo científico publicado en 2014

New concepts of clinical trials in rheumatoid arthritis: a boom of noninferiority trials

artículo científico publicado en 2016

Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis

artículo científico publicado en 2017

Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial

artículo científico publicado en 2005

OMERACT 10 Sharp Symposium: important findings in examination of imaging methods for measurement of joint damage in rheumatoid arthritis

artículo científico

Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.

artículo científico publicado en 2003

Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis?

artículo científico publicado en 2015

Percentage of progressors in imaging: can we ignore regressors?

scholarly article by Alexandre Sepriano et al published 26 February 2019 in RMD open

Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis

artículo científico publicado en 2017

Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis

artículo científico publicado en 2015

Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study

artículo científico publicado en 2009

Predictive markers in rapidly progressing rheumatoid arthritis

artículo científico publicado en 2007

Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis

artículo científico publicado en 2016

Predictors for health improvement in patients with fibromyalgia: a 2-year follow-up study

artículo científico publicado en 2013

Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative

artículo científico publicado en 2016

Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study

artículo científico publicado en 2005

Prevalence of Comorbidities and Risk Factors for Comorbidities in Patients with Spondyloarthritis in Latin America: A Comparative Study with the General Population and Data from the ASAS-COMOSPA Study

artículo científico publicado en 2017

Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study

artículo científico publicado en 2015

Prevalence of degenerative changes of the spine on magnetic resonance images and radiographs in patients aged 16-45 years with chronic back pain of short duration in the Spondyloarthritis Caught Early (SPACE) cohort

artículo científico publicado en 2015

Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis

artículo científico publicado en 2016

Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease

scientific article published on April 2013

Primer: challenges in randomized and observational studies

artículo científico publicado en 2007

Progression of rheumatoid arthritis on plain radiographs judged differently by expert radiologists and rheumatologists.

artículo científico publicado en 2004

Proposal for a new nomenclature of disease-modifying antirheumatic drugs

artículo científico publicado en 2013

Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design

scientific article published in August 2009

Quality in rheumatoid arthritis care

artículo científico

Quality indicators in rheumatoid arthritis: results from the METEOR database

artículo científico publicado en 2015

Radiographic progression depicted by probability plots: presenting data with optimal use of individual values

artículo científico publicado en 2004

Rate of adjudication of radiological progression in rheumatoid arthritis randomized controlled trials depending on preset limits of agreement: a pooled analysis from 15 randomized trials

artículo científico publicado el 16 de enero de 2013

Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria

scientific article published in August 2009

Relationship between disease activity indices and their individual components and radiographic progression in RA: a systematic literature review

artículo científico publicado en 2014

Relationship between types of radiographic damage and disability in patients with rheumatoid arthritis in the EURIDISS cohort: a longitudinal study

artículo científico publicado en 2014

Repair in rheumatoid arthritis, current status. Report of a workshop at OMERACT 8.

artículo científico publicado en 2007

Repair of erosions occurs almost exclusively in damaged joints without swelling

artículo científico publicado en 2009

Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational Studies

artículo científico

Resource utilisation and direct costs in patients with recently diagnosed fibromyalgia who are offered one of three different interventions in a randomised pragmatic trial

artículo científico publicado en 2015

Response to 'Neither earlier not late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study' by Moiseev et al

scientific article published on 30 October 2020

Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort

artículo científico publicado en 2018

Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Calvo-Aranda

artículo científico publicado en 2020

Response to: 'High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab' by Conticini et al

artículo científico publicado en 2020

Response to: 'Should patients starting biologics be screened for COVID-19?' by Cardenas-de la Garza et al

artículo científico publicado en 2020

Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort

artículo científico publicado en 2017

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

artículo científico

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?

artículo científico publicado en 2013

Searching for potential biomarkers that can be used as biomarkers for diagnosing ankylosing spondylitis

artículo científico publicado en 2008

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

artículo científico publicado en 2015

Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study

artículo científico publicado en 2018

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

artículo científico publicado en 2015

Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis

artículo científico publicado en 2014

Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort

artículo científico publicado en 2017

Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.

artículo científico publicado en 2007

Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials

artículo científico publicado en 2016

Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study

Social Role Participation Questionnaire for patients with ankylosing spondylitis: translation into Dutch, reliability and construct validity

artículo científico publicado en 2016

Social Role Participation in Patients With Ankylosing Spondylitis: A Cross-Sectional Comparison With Population Controls

artículo científico publicado en 2016

Social role participation and satisfaction with life: A study among patients with ankylosing spondylitis and population controls

artículo científico publicado en 2017

Sponyloarthritis features forecasting the presence of HLA-B27 or sacroiliitis on magnetic resonance imaging in patients with suspected axial spondyloarthritis: results from a cross-sectional study in the ESPeranza Cohort

artículo científico publicado en 2015

Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled Trial

artículo científico publicado en 2016

Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial

artículo científico publicado el 16 de mayo de 2012

Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.

artículo científico publicado en 2017

Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers

artículo científico publicado en 2009

The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis

artículo científico publicado en 2016

The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis

artículo científico publicado en 2010

The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study

artículo científico publicado en 2003

The feasibility and efficacy of a multidisciplinary intervention with aftercare meetings for fibromyalgia

artículo científico publicado en 2009

The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study

artículo científico publicado en 2017

Three handy tips and a practical guide to improve your propensity score models.

artículo científico publicado en 2019

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

artículo científico publicado en 2017

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

artículo científico

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

artículo científico publicado en 2014

Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction?

artículo científico publicado en 2007

Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life

Updating the OMERACT filter: core areas as a basis for defining core outcome sets

artículo científico publicado en 2014

Updating the OMERACT filter: discrimination and feasibility

artículo científico

Updating the OMERACT filter: implications for patient-reported outcomes

artículo científico

Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity

artículo científico publicado en 2014

Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires

artículo científico publicado en 2002

Use of multidimensional composite scores in rheumatology: parsimony versus subtlety

artículo científico publicado en 2020

Vitamin D status in spondyloarthritis: results of the ASAS-COMOSPA international study

artículo científico publicado en 2017

What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts

artículo científico publicado en 2020

When rheumatologists report that they agree with a guideline, does this mean that they practise the guideline in clinical practice? Results of the International Recommendation Implementation Study (IRIS).

artículo científico publicado en 2016